Trial Information
Summary: Duloxetine for the Treatment of Obsessive Compulsive Disorder
Do you suffer from obsessive compulsive disorder?
Participants Wanted for a Research Study on the
Effectiveness of Duloxetine (Cymbalta)
In Treating Obsessive Compulsive Disorder
Dr. Darin Dougherty of the Massachusetts General Hospital OCD Clinic
and Research Unit is conducting a research study on the use of duloxetine (Cymbalta) to reduce the symptoms associated with obsessive-compulsive
disorder (OCD). If you have OCD, you may be eligible to participate in this study.
To be eligible you must:
·be between 18-65 years old.
·live within 1 hour of Boston.
·be able to participate for 17 weeks.
·not be pregnant or breastfeeding.
If you are interested in this study and believe you are eligible,
please contact Mariko Jameson at (617) 726-9281.
|
Contact:
Johanna Thompson-Hollands
Massachusetts General Hospital - East
Rm 2612, Flr 2; 149-CNY Bldg. 149 13th Street
Charlestown, MA 02129
Telephone: 617-726-9281
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: July 7, 2008 at 2:42:14 PM